List of Renvela drug patents
Renvela is owned by Sanofi.
Renvela contains Sevelamer Carbonate.
Renvela has a total of 1 drug patent out of which 0 drug patents have expired.
Renvela was authorised for market use on 19 October, 2007.
Renvela is available in tablet;oral dosage forms.
The generics of Renvela are possible to be released after 27 October, 2025.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7985418 | SANOFI | Aliphatic amine polymer salts for tableting |
Oct, 2025
(2 years from now) | |
Drugs and Companies using SEVELAMER CARBONATE ingredient
Market Authorisation Date: 19 October, 2007
Treatment: NA
Dosage: TABLET;ORAL
RENVELA family patents
7
United States
2
Canada
2
Spain
2
Japan
2
China
2
European Union
1
Portugal
1
Hungary
1
Croatia
1
Hong Kong
1
Poland
1
Cyprus
1
Australia
1
Denmark
1
Mexico
1
Lithuania
1
Brazil
Renvela is owned by Genzyme.
Renvela contains Sevelamer Carbonate.
Renvela has a total of 1 drug patent out of which 0 drug patents have expired.
Renvela was authorised for market use on 18 February, 2009.
Renvela is available in for suspension;oral dosage forms.
The generics of Renvela are possible to be released after 06 December, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9095509 | GENZYME | Sachet formulation for amine polymers |
Dec, 2030
(7 years from now) | |
Drugs and Companies using SEVELAMER CARBONATE ingredient
Market Authorisation Date: 18 February, 2009
Treatment: NA
Dosage: FOR SUSPENSION;ORAL
RENVELA family patents
7
United States
3
Japan
2
Korea, Republic of
2
Hong Kong
2
Israel
2
China
2
European Union
1
Portugal
1
Slovenia
1
Hungary
1
New Zealand
1
Poland
1
Australia
1
Brazil
1
Denmark
1
Canada
1
Spain
1
Cyprus
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic